High Tower Advisors, LLC Ligand Pharmaceuticals Inc Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 5,142 shares of LGND stock, worth $546,491. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,142

Previous 4,876 5.46%

Holding current value

$546,491

Previous $410,000 25.61%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$82.7 - $110.11 $21,998 - $29,289	266 Added 5.46%	5,142 $515,000
Q2 2024 Aug 13, 2024	BUY	$68.53 - $87.91 $17,954 - $23,032	262 Added 5.68%	4,876 $410,000
Q4 2023 Feb 12, 2024	BUY	$49.57 - $72.63 $2,329 - $3,413	47 Added 1.03%	4,614 $329,000
Q3 2023 Nov 08, 2023	BUY	$58.86 - $72.67 $98,590 - $121,722	1,675 Added 57.92%	4,567 $273,000
Q2 2023 Aug 14, 2023	BUY	$69.53 - $79.33 $8,482 - $9,678	122 Added 4.4%	2,892 $208,000
Q1 2023 May 11, 2023	BUY	$65.67 - $77.08 $181,905 - $213,511	2,770 New	2,770 $203,000
Q3 2022 Nov 09, 2022	BUY	$0.01 - $107.56 $0 - $322	3 Added 0.1%	2,967 $256,000
Q1 2022 May 12, 2022	SELL	$94.99 - $151.56 $7,314 - $11,670	-77 Reduced 2.53%	2,964 $333,000
Q4 2021 Feb 10, 2022	BUY	$127.69 - $165.85 $2,298 - $2,985	18 Added 0.6%	3,041 $469,000
Q3 2021 Nov 12, 2021	BUY	$102.33 - $144.73 $2,046 - $2,894	20 Added 0.67%	3,023 $419,000
Q2 2021 Aug 06, 2021	SELL	$113.03 - $155.64 $1,017 - $1,400	-9 Reduced 0.3%	3,003 $394,000
Q1 2021 May 10, 2021	SELL	$99.52 - $215.83 $7,264 - $15,755	-73 Reduced 2.37%	3,012 $458,000
Q4 2020 Feb 10, 2021	BUY	$80.55 - $106.05 $3,383 - $4,454	42 Added 1.38%	3,085 $308,000
Q3 2020 Nov 13, 2020	BUY	$89.56 - $126.72 $6,627 - $9,377	74 Added 2.49%	3,043 $290,000
Q2 2020 Aug 10, 2020	BUY	$68.28 - $123.65 $202,723 - $367,116	2,969 New	2,969 $332,000
Q4 2018 Feb 14, 2019	SELL	$128.36 - $272.13 $127,076 - $269,408	-990 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$211.18 - $274.49 $209,068 - $271,745	990 New	990 $272,000
Q4 2017 Feb 14, 2018	SELL	$128.36 - $147.04 $574,282 - $657,856	-4,474 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$120.91 - $137.94 $540,951 - $617,143	4,474	4,474 $613,000

Others Institutions Holding LGND

# of Institutions

255

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.79B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Ligand Pharmaceuticals Inc Transaction History